Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)

Keyphrases

• Coronary Artery Disease 100%
• Bleeding 100%
• Target Lesion Failure 100%
• 1-year Outcome 100%
• Dual Antiplatelet Therapy Cessation 100%
• Mascot 100%
• COMBO Stent 100%
• Myocardial Infarction 66%
• Cardiac Death 66%
• Target Lesion Revascularization 66%
• Bleeding Academic Research Consortium 66%
• Hazard Ratio 33%
• Confidence Interval 33%
• Major Bleeding 33%
• No Significant Difference 33%
• Clinical Outcomes 33%
• Cox Regression 33%
• Elderly Patients 33%
• Dual Antiplatelet Therapy 33%
• Stent Thrombosis 33%
• Bleeding Risk 33%
• Multicenter Cohort Study 33%
• Young Patients 33%
• Older Patients 33%
• All-comers 33%
• Regression Method 33%
• Coronary Intervention 33%
• Ischemic Events 33%
• Capture Technology 33%
• Non-target 33%
• Rapid Endothelialization 33%
• Biodegradable Polymer Sirolimus-eluting Stent 33%
• Endothelial Progenitor Cell Capture 33%

Medicine and Dentistry

• Antiplatelet 100%
• Coronary Artery Disease 100%
• Target Lesion 75%
• Bleeding 50%
• Myocardial Infarction 50%
• Heart Death 50%
• Target Lesion Revascularization 50%
• Hazard Ratio 25%
• Major Bleeding 25%
• Elderly Patient 25%
• Rapamycin 25%
• Proportional Hazards Model 25%
• Stent Thrombosis 25%
• Cohort Analysis 25%
• Stenting 25%
• Endothelial Progenitor Cell 25%